These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. CSF-1-activated macrophages are target-directed and essential mediators of Schwann cell dedifferentiation and dysfunction in Cx32-deficient mice. Groh J, Klein I, Hollmann C, Wettmarshausen J, Klein D, Martini R. Glia; 2015 Jun; 63(6):977-86. PubMed ID: 25628221 [Abstract] [Full Text] [Related]
27. Aberrant trafficking of a Leu89Pro connexin32 mutant associated with X-linked dominant Charcot-Marie-Tooth disease. Da Y, Wang W, Liu Z, Chen H, Di L, Previch L, Chen Z. Neurol Res; 2016 Oct 22; 38(10):897-902. PubMed ID: 27367520 [Abstract] [Full Text] [Related]
29. A start codon CMT1X mutation associated with transient encephalomyelitis causes complete loss of Cx32. Sargiannidou I, Kim GH, Kyriakoudi S, Eun BL, Kleopa KA. Neurogenetics; 2015 Jul 22; 16(3):193-200. PubMed ID: 25771809 [Abstract] [Full Text] [Related]
30. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice. Klein D, Patzkó Á, Schreiber D, van Hauwermeiren A, Baier M, Groh J, West BL, Martini R. Brain; 2015 Nov 22; 138(Pt 11):3193-205. PubMed ID: 26297559 [Abstract] [Full Text] [Related]
31. AAV1.NT-3 gene therapy for X-linked Charcot-Marie-Tooth neuropathy type 1. Ozes B, Myers M, Moss K, Mckinney J, Ridgley A, Chen L, Bai S, Abrams CK, Freidin MM, Mendell JR, Sahenk Z. Gene Ther; 2022 Apr 22; 29(3-4):127-137. PubMed ID: 33542455 [Abstract] [Full Text] [Related]
37. Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X. Kleopa KA, Zamba-Papanicolaou E, Alevra X, Nicolaou P, Georgiou DM, Hadjisavvas A, Kyriakides T, Christodoulou K. Neurology; 2006 Feb 14; 66(3):396-402. PubMed ID: 16476939 [Abstract] [Full Text] [Related]